Matthew J. Meyer

The publication record attributed to this name spans widely different topics—cancer drug discovery (KRAS inhibitors, tumor microenvironment), stroke rehabilitation and outcomes, critical care sustainability, community paramedicine, and even mycology (fungal taxonomy)—suggesting the data likely aggregates multiple distinct researchers sharing this name rather than one coherent research program. Because of this, prospective students should treat any single 'research area' summary with caution and verify authorship and affiliation directly. Based on the most frequent themes present, the profile touches on cancer biology and drug development, stroke care, and health system/sustainability topics.

Publication counts were fairly steady (6-16 per year) from 2017-2022, spiked sharply to 114 in 2023, then dropped back to single digits through 2026, a pattern consistent with multiple authors of the same name being merged rather than one individual's steady output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026